Eligibility
Am I Eligible for Tirzepatide?
GLP-1 medications are prescribed based on your BMI, your health and your goals. Use the BMI check below, review the criteria, then book a free consultation. A licensed physician makes the final decision.
Free check
Check your BMI in seconds
Enter your height and weight to see your BMI and whether you are in the range where GLP-1 medication is usually considered.
Criteria
Who usually qualifies
These follow the FDA-approved indication for chronic weight management.
You may qualify if you are
- Adults 18 or older
- BMI of 30 or higher, or
- BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnea
- Located in a U.S. state where our physicians are licensed
- Able to take a once-weekly medication and follow up with your care team
Tirzepatide may not be right for you if you have
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Pregnant, planning pregnancy or breastfeeding
- Known serious allergy to tirzepatide, semaglutide or their ingredients
- History of pancreatitis, severe gastrointestinal disease such as gastroparesis, or certain other conditions your physician will ask about
Weight-related conditions
What counts as a weight-related condition?
Common examples include high blood pressure (hypertension), type 2 diabetes or prediabetes, high cholesterol or triglycerides, obstructive sleep apnea, and cardiovascular disease. Tell your physician about every condition and medication, including supplements, so they can decide safely.
Tirzepatide can make birth control pills less effective for a period after starting or increasing the dose. Your physician will explain how to protect against pregnancy during treatment. See the prescribing information.
Important safety information
Warning: risk of thyroid C-cell tumors. In rodent studies, tirzepatide caused thyroid C-cell tumors. It's unknown whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people. Don't use tirzepatide if you or a family member have had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Serious side effects can include pancreatitis, gallbladder problems, low blood sugar (especially with insulin or a sulfonylurea), kidney problems, serious allergic reactions and vision changes in people with type 2 diabetes. Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain and indigestion. Not for use during pregnancy. Full Prescribing Information
FAQ
Common questions
Who qualifies for tirzepatide?
Most adults who qualify have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea. Your physician makes the final decision.
Who should not take tirzepatide?
Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, anyone who is pregnant or breastfeeding, and anyone with a serious allergy to tirzepatide. Your physician also screens for pancreatitis, gallbladder disease, kidney problems and other conditions.
Can I switch from semaglutide?
Often, yes. Your physician reviews your current medication and dose, decides when to switch and chooses a safe starting dose. Do not take two GLP-1 medications at the same time.
Keep exploring